1-4 of 4
Parisa Asvadi
Close
Sort by
Journal Articles

The Anti-Kappa Monoclonal Antibody MDX-1097 Synergizes with Immunomodulatory Drugs to Enhance Antibody-Dependent Cell Cytotoxicity of Multiple Myeloma Cells

Andrew R Cuddihy, PhD, Parisa Asvadi, PhD, Rosanne Dunn, PhD, Tiffany T. Khong, BSc, PhD, Andrew Spencer, MD
Journal: Blood
Blood (2012) 120 (21): 4012.
https://doi.org/10.1182/blood.V120.21.4012.4012
Published: 2012
Journal Articles

MDX-1097 Binds Specifically to Kappa Myeloma Cells and Anti-Tumour Activity Is Mediated by Multiple Effector Cells.

Mae Wong, PhD, Parisa Asvadi, PhD, Rosanne Dunn, PhD, Darren Jones, Douglas Campbell, PhD, Andrew Spencer, DM
Journal: Blood
Blood (2009) 114 (22): 1846.
https://doi.org/10.1182/blood.V114.22.1846.1846
Published: 2009
Journal Articles

A Monoclonal Antibody Specific for Free Human Kappa Light Chains Induces Apoptosis of Multiple Myeloma Cells and Exhibits Anti-Tumor Activity In Vivo .

Parisa Asvadi, Darren R. Jones, Rosanne D. Dunn, Andre B.H. Choo, Matthew J. Raison, Robert L. Raison
Journal: Blood
Blood (2004) 104 (11): 2416.
https://doi.org/10.1182/blood.V104.11.2416.2416
Published: 2004
Journal Articles

Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies

Parisa Asvadi, Zohra Ahmadi, Beng H. Chong
Journal: Blood
Blood (2003) 102 (5): 1670–1677.
https://doi.org/10.1182/blood-2002-07-2175
Published: 2003